Get started

Financials · SNWV

SANUWAVE Health Inc. (SNWV) financials

For the twelve months ended Jun 30, 2026, SANUWAVE Health Inc. reported $44.02M of revenue and $15.26M of net income.

Revenue, TTM
$44.02M
Revenue growth, YoY
+12.7%
Net income, TTM
$15.26M
Net margin
34.7%
Free cash flow, TTM
$4.24M
EPS, diluted, TTM
$0.92
Cash
$9.38M
P/E
1.23
P/S
0.43
Market cap
$18.8M
Annual revenue$44.05M
FY2016FY2025
Annual net income$11.81M
FY2016FY2025
Annual free cash flow$1.93M
FY2016FY2025

SNWV revenue and earnings growth

SNWV revenueQ2 2026$9.74M

Quarter YoY
-3.1%
QoQ
+1.2%
FY YoY
+35.0%
5Y CAGR
+61.1%
10Y CAGR
+46.5%

SNWV revenue was $9.74M in fiscal Q2 2026 (ended Jun 30, 2026), down 3.1% from a year earlier and up 1.2% from the prior quarter. For the full fiscal 2025 it was $44.05M, up 35.0% from fiscal 2024. Compound annual growth was +61.1% over 5 years and +46.5% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

SNWV net incomeQ2 2026-$682.0K

SNWV net income was -$682.0K in fiscal Q2 2026 (ended Jun 30, 2026), compared with $551.0K a year earlier. For the full fiscal 2025 it was $11.81M, compared with -$33.08M in fiscal 2024. Fiscal 2025 is the highest of the 15 fiscal years on file.

SNWV EPSQ2 2026-$0.08

SNWV diluted EPS was -$0.08 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.04 a year earlier. For the full fiscal 2025 it was $0.41.

SNWV free cash flowQ2 2026$91.0K

QoQ
-75.7%
FY YoY
-1.6%

SNWV free cash flow was $91.0K in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$166.0K a year earlier and down 75.7% from the prior quarter. For the full fiscal 2025 it was $1.93M, down 1.6% from fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$44.05M$32.63M$20.40M$16.74M$13.01M$4.06M$1.03M$1.85M$738.5K$1.38M
Cost of revenue$10.08M$8.08M$6.04M$4.33M$4.99M$1.16M$538.9K$693.7K$242.0K$565.1K
Gross profit$33.97M$24.55M$14.36M$12.41M$8.02M$2.90M$489.8K$1.16M$496.6K$810.9K
Research and development$1.35M$673.0K$579.0K$567.0K$1.10M$1.25M$1.18M$981.7K$1.29M$1.13M
Selling, general and admin$19.37M$12.92M$8.67M$12.56M$11.69M$13.72M$6.44M$6.81M$3.00M$2.67M
Operating income$4.95M$3.85M-$540.0K-$8.95M-$14.14M-$25.20M-$8.79M-$7.18M-$3.82M-$3.32M
Interest expense------$1.84M$4.50M$1.14M$855.0K
Pre-tax income$11.90M-$33.06M--------
Income tax$86.0K$27.0K$4.0K$2.0K$28.0K$0$0$0$0$0
Net income$11.81M-$33.08M-$25.81M-$10.29M-$27.26M-$30.94M-$10.43M-$11.63M-$5.54M-$6.44M
EPS, basic$1.38-$7.41-$12.19-$0.02-$0.05-$0.08-$0.05-$0.08-$0.04-$0.06
EPS, diluted$0.41-$7.41-$12.19-$0.02-$0.05-$0.08-$0.05-$0.08-$0.04-$0.06
Diluted shares9.1M4.5M2.1M549.5M518.4M378.1M203.6M149.5M138.8M107.6M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$11.96M$10.24M$1.80M$1.15M$619.0K$2.44M$1.76M$364.5K$730.2K$133.6K
Receivables$5.42M$3.33M$3.31M$4.03M$2.42M$2.36M$75.5K$234.8K$152.5K$460.8K
Inventory$5.93M$4.15M$2.95M$868.0K$1.04M$2.96M$543.0K$357.8K$231.5K$232.0K
Current assets$24.63M$18.40M$9.78M$6.62M$4.40M$7.93M$2.50M$1.08M$1.20M$914.1K
Goodwill$7.26M$7.26M$7.26M$7.26M$7.26M$7.26M$0---
Total assets$37.34M$30.12M$22.42M$19.87M$18.62M$23.03M$3.38M$1.18M$1.28M$1.00M
Current liabilities$17.85M$45.42M$64.75M$60.22M$56.26M$36.17M$12.42M$16.49M$11.16M$7.92M
Short-term debt$5.75M---$25.39M$16.59M$587.2K$1.88M$0$47.4K
Long-term debt$16.14M---$875.0K$143.0K----
Total debt$21.89M---$26.26M$16.74M---$5.37M
Total liabilities$35.72M$45.91M$65.59M$60.88M$57.58M$36.74M$13.45M$16.53M$11.16M$7.92M
Shareholders' equity$1.62M-$15.79M-$44.55M-$41.01M-$38.96M-$13.72M-$10.06M-$15.36M-$9.88M-$6.91M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow$3.88M$2.46M-$4.54M-$17.17M-$6.41M-$12.72M-$6.41M-$3.62M-$1.53M-$3.20M
Capital expenditures$1.94M$490.0K$0-$529.0K$53.0K$53.9K$42.9K$0$10.4K
Free cash flow$1.93M$1.97M-$4.54M--$6.94M-$12.77M-$6.46M-$3.66M-$1.53M-$3.21M
Investing cash flow$3.43M-$490.0K$21.0K$332.0K-$529.0K-$20.05M-$53.9K-$42.9K$0-$8.8K
Financing cash flow-$5.59M$6.35M$5.21M$17.38M$5.12M$33.45M$7.86M$3.32M$2.12M$3.21M
Stock-based compensation$4.85M$1.51M$0-$0$22.0K$333.4K$2.48M$768.1K$547.8K
Depreciation and amortization$974.0K$788.0K$1.03M$952.0K$1.24M$299.0K$71.2K---

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY35.0%60.0%21.8%28.7%220.7%294.4%-44.4%150.5%-46.3%42.5%
Gross margin77.1%75.2%70.4%74.1%61.7%71.4%47.6%62.5%67.2%58.9%
Operating margin11.2%11.8%-2.6%-53.5%-108.7%-621.1%-854.9%-388.1%-517.8%-241.0%
Net margin26.8%-101.4%-126.5%-61.5%-209.5%-762.6%-1013.9%-628.7%-749.9%-467.9%
Free cash flow margin4.4%6.0%-22.2%--53.3%-314.8%-628.4%-198.1%-207.0%-233.3%
Return on equity729.6%---------
Return on assets31.6%-109.8%-115.1%-51.8%-146.4%-134.4%-308.4%-987.6%-433.1%-640.8%
Current ratio1.380.410.150.110.080.220.200.070.110.12
Debt to equity13.52---------

Source: XBRL data SANUWAVE Health Inc. files with the SEC, latest filing dated Aug 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

SNWV peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
SNWV$44.02M+12.7%$15.26M34.7%$18.8M
SYK$26.30B+7.9%$3.62B13.8%$124.05B
MMM$25.25B+1.7%$3.54B14.0%$95.67B
BSX$21.07B+8.9%$3.50B16.6%$61.96B
BDX$23.25B+17.4%$941.00M4.0%$57.71B
MDLN$30.68B-$683.00M2.2%$52.13B
RMD$5.73B+9.0%$1.59B27.8%$33.10B
DXCM$5.10B+13.0%$991.00M19.4%$29.62B
WST$3.40B+12.6%$638.90M18.8%$27.85B

SNWV FAQ

9 questions
  • What is SNWV revenue?
    SANUWAVE Health Inc. (SNWV) reported $44.02M of revenue for the twelve months ended Jun 30, 2026. That is up 12.7% from the year before. Revenue for fiscal 2025 was $44.05M.
  • Is SNWV profitable?
    Yes. SANUWAVE Health Inc. earned $15.26M in net income for the twelve months ended Jun 30, 2026, a net margin of 34.7%.
  • How much cash and debt does SNWV have?
    SANUWAVE Health Inc. reported $9.38M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is SNWV revenue growing?
    SANUWAVE Health Inc.'s revenue changed +35.0% in fiscal 2025, to $44.05M. Its compound annual growth rate was +61.1% over 5 years and +46.5% over 10 years.
  • What is SNWV gross margin?
    SANUWAVE Health Inc.'s gross profit was $33.60M on $44.02M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 76.3%.
  • What is SNWV free cash flow?
    SANUWAVE Health Inc. generated $4.24M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $5.22M less capital expenditures.
  • What is SNWV earnings per share?
    Diluted earnings per share were $0.92 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did SNWV last report financial results?
    The latest statements here come from SANUWAVE Health Inc.'s 10-Q filed on Aug 6, 2026, covering the period ended Jun 30, 2026.
  • Where does this SNWV financial data come from?
    Quantisnow builds these statements from the structured XBRL data SANUWAVE Health Inc. files with the SEC. It is provided for information only and is not investment advice.